Cargando…
Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer
Approximately 70% of all breast cancer cases are estrogen receptor-alpha positive (ERα+) and any ERα signaling pathways deregulation is critical for the progression of malignant mammary neoplasia. ERα acts as a transcription factor that promotes the expression of estrogen target genes associated wit...
Autores principales: | Tecalco-Cruz, Angeles C., Macías-Silva, Marina, Ramírez-Jarquín, Josué Orlando, Ramírez-Jarquín, Uri Nimrod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044904/ https://www.ncbi.nlm.nih.gov/pubmed/35498431 http://dx.doi.org/10.3389/fendo.2022.867448 |
Ejemplares similares
-
Identification of genes modulated by interferon gamma in breast cancer cells
por: Tecalco-Cruz, Angeles C., et al.
Publicado: (2021) -
Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer
por: Tecalco-Cruz, Angeles C, et al.
Publicado: (2018) -
Proteolysis-targeting chimeras and their implications in breast cancer
por: Tecalco-Cruz, Angeles C., et al.
Publicado: (2021) -
TRIM25: A central factor in breast cancer
por: Tecalco-Cruz, Angeles C, et al.
Publicado: (2021) -
Epigenetic basis of Alzheimer disease
por: Tecalco-Cruz, Angeles C, et al.
Publicado: (2020)